This latter possibility, however, was questioned since genetic inhibition of eIF2α phosphorylation was not able to revert the Aβ-dependent BACE1 increase or the amyloid pathology in transgenic AD mice [36]. This evidence concerns the gene BACE1 and Alzheimer disease.